Skip to main content
. Author manuscript; available in PMC: 2011 Apr 6.
Published in final edited form as: Kidney Int. 2010 Mar 10;77(11):962–973. doi: 10.1038/ki.2010.40

Figure 9. Hepatocyte growth factor (HGF) prevents podocyte apoptosis induced by adriamycin (ADR) in vitro.

Figure 9

Human podocytes were treated with a lethal dose of ADR (20 μg/ml) in the absence or presence of HGF (20 ng/ml) for 12 h. (a) Representative micrographs of phase-contrast, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining and immunostaining for cleaved caspase-3. (b) Quantitative data of the detached cells after various treatments as indicated. (c) Quantitative data showing the TUNEL-positive cells after various treatments as indicated. (d) Quantitative data showing the cleaved caspase-3-positive cells after various treatments as indicated. *P<0.05 versus controls; †P<0.05 versus ADR alone (n = 4).